BridgeBio is substantially boosted this development of an innovative solution for amyloid heart disease, utilizing Attruby. Early trial data suggests promising benefits for those affected from the severe disease. This focus represents researchers’ dedication to addressing unmet medical requirements in the cardiology space. Attruby: BridgeBio's N